Personalized math could make blood thinner safer and faster
NCT ID NCT07250763
Summary
This study is testing if a personalized starting dose for the blood thinner heparin works better than the standard one-size-fits-all approach. It involves 145 adults being treated for blood clots or certain heart conditions. Researchers will see if using a formula based on a patient's gender, weight, and kidney function helps get the medication to the right level in the blood faster and more safely.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY EMBOLISM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Inova Alexandria Hospital
Alexandria, Virginia, 22304, United States
Conditions
Explore the condition pages connected to this study.